Last reviewed · How we verify

NCT03642808: OPTICHUTE

Optimisation of Falls Prevention After Low-energy Osteoporotic Fractures: Feasibility Study

Status unknown NA Last updated 27 April 2023
What this trial tests

NA trial testing rehabilitation program in Osteoporotic Fractures in 17 participants. Status unknown.

Timeline
27 July 2018
Primary endpoint
27 November 2019
31 December 2023

Quick facts

Lead sponsorFondation Hôpital Saint-Joseph
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment17
Start date27 July 2018
Primary completion27 November 2019
Estimated completion31 December 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

60 and older, any sex, with Osteoporotic Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Within the Groupe Hospitalier Paris Saint-Joseph (GHPSJ), a reinforced medical care of osteoporosis ('Fracture Liaison service') was organized for osteoporotic fractured patients. The evaluation of benefits of this program through a randomized study showed an improvement in diagnostic tests performed (bone densitometry) and antiosteoporotic treatment initiated (OPTIPOST study, being published in BMJ). However, of 323 patients included, 91 presented a new fracture within 12 months. Among them, 40/126 patients (31.7%) were in the reinforced medical care arm. This result clearly demonstrates the need for a specific medical care program for patients with osteoporotic fracture falling regularly.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of rehabilitation program

Trials testing the same drug.

Other recruiting trials for Osteoporotic Fractures

Currently open trials in the same condition.

Other Fondation Hôpital Saint-Joseph trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03642808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing